Wei LJ - Search Results

1

Utility of Restricted Mean Survival Time for Analyzing Time to Nursing Home Placement Among Patients With Dementia.

Kim DH, Li X, Bian S, Wei LJ, Sun R. Kim DH, et al. Among authors: wei lj. JAMA Netw Open. 2021 Jan 4;4(1):e2034745. doi: 10.1001/jamanetworkopen.2020.34745. JAMA Netw Open. 2021. PMID: 33507253 Free PMC article.

2

Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results.

Kim DH, Uno H, Wei LJ. Kim DH, et al. Among authors: wei lj. JAMA Cardiol. 2017 Nov 1;2(11):1179-1180. doi: 10.1001/jamacardio.2017.2922. JAMA Cardiol. 2017. PMID: 28877311 Free PMC article. No abstract available.

3

Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio.

Pak K, Uno H, Kim DH, Tian L, Kane RC, Takeuchi M, Fu H, Claggett B, Wei LJ. Pak K, et al. Among authors: wei lj. JAMA Oncol. 2017 Dec 1;3(12):1692-1696. doi: 10.1001/jamaoncol.2017.2797. JAMA Oncol. 2017. PMID: 28975263 Free PMC article.

4

Estimating Treatment Effect With Clinical Interpretation From a Comparative Clinical Trial With an End Point Subject to Competing Risks.

Zhao L, Tian L, Claggett B, Pfeffer M, Kim DH, Solomon S, Wei LJ. Zhao L, et al. Among authors: wei lj. JAMA Cardiol. 2018 Apr 1;3(4):357-358. doi: 10.1001/jamacardio.2018.0127. JAMA Cardiol. 2018. PMID: 29541747 Free PMC article.

5

Interpreting the Benefit of Trifluridine/Tipiracil in Metastatic Colorectal Cancer With Respect to Progression-Free Survival and Overall Survival.

Sun R, Horiguchi M, Wei LJ. Sun R, et al. Among authors: wei lj. J Clin Oncol. 2018 May 1;36(13):1378-1379. doi: 10.1200/JCO.2017.77.5643. Epub 2018 Mar 20. J Clin Oncol. 2018. PMID: 29558278 No abstract available.

6

Adding a new analytical procedure with clinical interpretation in the tool box of survival analysis.

Uno H, Claggett B, Tian L, Fu H, Huang B, Kim DH, Wei LJ. Uno H, et al. Among authors: wei lj. Ann Oncol. 2018 May 1;29(5):1092-1094. doi: 10.1093/annonc/mdy109. Ann Oncol. 2018. PMID: 29617717 Free PMC article. No abstract available.

7

Evaluating Treatment Effect Based on Duration of Response for a Comparative Oncology Study.

Huang B, Tian L, Talukder E, Rothenberg M, Kim DH, Wei LJ. Huang B, et al. Among authors: wei lj. JAMA Oncol. 2018 Jun 1;4(6):874-876. doi: 10.1001/jamaoncol.2018.0275. JAMA Oncol. 2018. PMID: 29710201 Free PMC article.

8

Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study.

Horiguchi M, Tian L, Uno H, Cheng S, Kim DH, Schrag D, Wei LJ. Horiguchi M, et al. Among authors: wei lj. JAMA Oncol. 2018 Jun 1;4(6):881-882. doi: 10.1001/jamaoncol.2018.0518. JAMA Oncol. 2018. PMID: 29801103 Free PMC article.

9

Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma.

Uno H, Kim DH, Wei LJ. Uno H, et al. Among authors: wei lj. JAMA Oncol. 2018 Aug 1;4(8):1135-1136. doi: 10.1001/jamaoncol.2018.0881. JAMA Oncol. 2018. PMID: 29902302 No abstract available.

10

Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time.

McCaw ZR, Orkaby AR, Wei LJ, Kim DH, Rich MW. McCaw ZR, et al. Among authors: wei lj. Am J Med. 2019 Jan;132(1):13-15. doi: 10.1016/j.amjmed.2018.07.026. Epub 2018 Aug 1. Am J Med. 2019. PMID: 30076822 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

322 results

Search Page

Filters